Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sylvia Adams | Researchclopedia

Back to researchers

Sylvia Adams

NYU Langone Health ORCID

347

Works

31,069

Citations

72

h-index

157

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Advanced Breast Cancer Therapies

Affiliations

Supélec2013–2014

University of California, Riverside2009–2009

Roche (Switzerland)2019–2019

Merck & Co., Inc., Rahway, NJ, USA (United States)2016–2016

American Society of Clinical Oncology2010–2011

Top Works

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Peter Schmid,Sylvia Adams,et al.

20184,270 citations

Chronic Obstructive Pulmonary Disease (COPD) Research

Cancer Genomics and Diagnostics

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado,Carsten Denkert,et al.

20143,067 citations

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams,Robert J. Gray,et al.

20141,328 citations

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

Peter Schmid,Hope S. Rugo,et al.

20191,174 citations

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi,Damien Drubay,et al.

2019859 citations

NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis

Samantha Alvarez,Vladislav O. Sviderskiy,et al.

2017788 citations

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

Shona Hendry,Roberto Salgado,et al.

2017786 citations

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Sylvia Adams,P. Schmid,et al.

2018772 citations

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

Shona Hendry,Roberto Salgado,et al.

2017707 citations